Amorphous silica nanoparticles induced spleen and liver toxicity after acute intravenous exposure in male and female rats

Abstract

Synthetic amorphous silica (SAS) nanomaterial – consisting of aggregates and agglomerates of primary silicon dioxide (SiO₂) particles in the nanorange (<100 nm) – is commonly used as excipient in pharmaceuticals, in cosmetics and as food additive (E551). The available data suggest that SAS nanoparticles (NP) after intravenous (IV) exposure persist in liver and spleen; however, insufficient data exist to verify whether SAS may also induce adverse effects. The aim of the present study was to verify the potential long-term effects of SAS NP (NM-203) on spleen and liver as target organs following short-term exposure. Adult male and female Sprague-Dawley rats were treated by IV injection in the tail vein with a single (1-day) dose (SD) and repeated (5-day) doses (RD) of 20 mg/kg bw per day of SAS dispersed in sterile saline solution as vehicle. Histopathological examinations of target organs were performed after 90 days. Tissue biodistribution and full characterization of NM-203, primary particle size 13–45 nm, was performed within the framework of the Nanogenotox project. No mortality or general toxicity occurred; histopathological analysis showed splenomegaly in the RD group accompanied by inflammatory granulomas in both sexes. Granulomas were also present in liver parenchyma in the RD (both sexes) and SD groups (male only). The histopathological results indicated that SAS NP have the potential to persist and induce sex-specific chronic inflammatory lesions in spleen and liver upon short-term treatment. Overall, the data showed that the widespread use of silica in drugs might elicit chronic reactions in spleen and liver prompting to the need of further investigations on the safety of SAS NP.

Keywords

splenomegaly granuloma long-term effects excipient

Get full access to this article

View all access options for this article.

References

Alvarez-Berrios

Vivero-Escoto

(2016) In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin. International Journal of Nanomedicine 11: 6251–6265.

Boccuni

Ferrante

Tombolini

. et al. (2020) Occupational exposure to graphene and silica nanoparticles. Part I: Workplace measurements and samplings. Nanotoxicology 14(9): 1280–1300.

De Jong

Jacobsen

Wallin

. et al. (2013) NANOGENOTOX, Deliverable 7: Identification of target organs and biodistribution including ADME parameters, Final Report. Netherlands: National Institute for Public Health and Environment (RIVM), Bilthoven. Available at: http://www.Nanogenotox.Eu/Files/PDF/DELIVRABLES2/Deliverable7__biodistribution.Pdf (accessed 1 July 2016).

Di Cristo

Boccuni

Iavicoli

. et al. (2020) A human-relevant 3D in vitro platform for an effective and rapid simulation of workplace exposure to nanoparticles: Silica nanoparticles as case study. Nanomaterials 10(9): 1761.

European food safety authority (EFSA) (2018) Re-evaluation of silicon dioxide (E551) as a food additive. EFSA Journal 16(1): 5088.

Fernández-Cruz

Hernández-Moreno

Catalán

. et al. (2018) Quality evaluation of human and environmental toxicity studies performed with nanomaterials – The GUIDEnano approach. Environmental Science: Nano 5: 381–397.

Fruijtier-Polloth

(2016) The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E551). Archives of Toxicology 90(12): 2885–2916.

Gryshchuk

Galagan

(2016) Silica nanoparticles effects on blood coagulation proteins and platelets. Biochemistry Research International 2016: 2959414.

Guichard

Maire

Sebillaud

. et al. (2015) Genotoxicity of synthetic amorphous silica nanoparticles in rats following short-term exposure. Part 2: Intratracheal instillation and intravenous injection. Environmental and Molecular Mutagenesis 56(2): 228–244.

10.

Jensen

Clausen

Birkedal

. et al. (2011) NANOGENOTOX, WP 4: Physicochemical characterisation of manufactured nanomaterials (MNs) and exposure media (EMs). Available at: https://www.anses.fr/en/system/files/Work_package_5.pdf

11.

Maranghi

Tassinari

Moracci

. et al. (2013) Dietary exposure of juvenile female mice to polyhalogenated seafood contaminants (HBCD, BDE-47, PCB-153, TCDD): Comparative assessment of effects in potential target tissues. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 56: 443–449.

12.

Murugadoss

Lison

Godderis

. et al. (2017) Toxicology of silica nanoparticles: An update. Archives of Toxicology 91(9): 2967–3010.

13.

Nanogenotox: The project (2013) Available at: http://www.Nanogenotox.Eu/Files/PDF/Nanogenotox_web.Pdf. (accessed September 2020)

14.

Rasmussen

Mech

Mast

, et al. (2013) Synthetic Amorphous Silicon Dioxide (NM-200, NM-201, NM-202, NM-203, NM-204): Characterisation and Physico-Chemical Properties. EUR 26046. Luxembourg (Luxembourg): Publications Office of the European Union, 2013. JRC83506. Available at: http://publications.jrc.ec.europa.eu/repository/handle/JRC83506 (accessed September 2020).

15.

Suttie

(2006) Histopathology of the spleen. Toxicol Pathol. 34(5):466–503.

16.

Tassinari

Di Felice

Butteroni

. et al. (2020) Hazard identification of pyrogenic synthetic amorphous silica (NM-203) after sub-chronic oral exposure in rat: A multitarget approach. Food and Chemical Toxicology 137: 111168.

17.

van Kesteren

Cubadda

Bouwmeester

. et al. (2015) Novel insights into the risk assessment of the nanomaterial synthetic amorphous silica, additive E551, in food. Nanotoxicology 9(4): 442–452.

18.

Waegeneers

Brasseur

Van Doren

et al. (2018) Short-term biodistribution and clearance of intravenously administered silica nanoparticles. Toxicol Rep. 23(5): 632–638.

19.

Duan

. et al. (2017) Silica nanoparticles induce liver fibrosis via TGF-beta1/Smad3 pathway in ICR mice. International Journal of Nanomedicine 12: 6045–6057.

20.

Zhuravskii

Yukina

Kulikova

. et al. (2016) Mast cell accumulation precedes tissue fibrosis induced by intravenously administered amorphous silica nanoparticles. Toxicology Mechanisms and Methods 26(4): 260–269.